Cayman Islands
|
001-40122
|
98-1574672
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
51 Astor Place, 10th Floor
New York, NY |
|
10003
|
(Address of principal executive offices)
|
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s) |
Name of each exchange
on which registered |
Class A Ordinary Shares, par value $0.0001 per share
|
ARYD
|
The Nasdaq Capital Market
|
Item 3.01.
|
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.
|
Dated: January 30, 2024
|
|
|
|
|
|
|
ARYA Sciences Acquisition Corp IV
|
|
|
|
|
|
By:
|
/s/ Michael Altman
|
|
Name:
|
Michael Altman
|
|
Title:
|
Chief Financial Officer
|